Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Apricus Biosciences -- Ignore unavailable to you. Want to Upgrade?

To: mokelumne river who wrote (1752)	3/9/2016 8:59:32 PM
From: eico20	Read Replies (1) \| Respond to of 2026

good points James, and I would add that pascoe says if Allergan/Pfizer opts out of marketing Vitaros he has 3 others who would, so clearly the approval comes first and a partner is a definite possibility, the EU sales are growing without the biggest player - sandoz, so they really need to get Sandoz back on the table, an approval and launch in Brazill would also be good news.